News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Sun Pharmaceutical Industries Ltd Announces US FDA Approval for Generic Venlafaxine Extended Release Tablets
August 19, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MUMBAI, India--(BUSINESS WIRE)--Sun Pharma announced that USFDA has granted an approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Venlafaxine Hydrochloride Extended Release tablets.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Adcomms
Moderna’s once-rebuffed mRNA flu shot to face scrutiny from FDA adcomm
May 22, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions
May 20, 2026
·
2 min read
·
Nick Paul Taylor
Regulatory
Pazdur declines to announce candidacy for vacated FDA commissioner role
May 20, 2026
·
4 min read
·
Heather McKenzie
FDA
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
May 20, 2026
·
1 min read
·
Jef Akst
